-
261
Recent advances in the management of choreas
Published 2013-03-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
262
Identifying Cladribine prescription pattern in MS: an Italian multicentre study
Published 2025-01-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
263
Shifting from the treat-to-target to the early highly effective treatment approach in patients with multiple sclerosis – real-world evidence from Germany
Published 2024-03-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
264
Genetic and phenotypic analyses of PRRT2 positive and negative paroxysmal kinesigenic dyskinesia
Published 2024-01-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
265
Efficacy and safety of rufinamide in pediatric epilepsy
Published 2013-05-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
266
Erratum
Published 2012-05-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
267
Therapeutic effect on experimental acute cerebral infarction is enhanced after nanoceria labeling of human umbilical cord mesenchymal stem cells
Published 2019-07-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
268
Patient-reported treatment satisfaction in essential tremor: levels of satisfaction and predictors of satisfaction
Published 2024-10-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
269
Outcome, efficacy and safety of endovascular thrombectomy in ischaemic stroke according to time to reperfusion: data from a multicentre registry
Published 2019-03-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
270
Cerebral air embolism following a hemodialysis session successfully treated with hyperbaric oxygen: a case report
Published 2024-10-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
271
The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis
Published 2019-03-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
272
Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database
Published 2024-04-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
273
Isoniazid in autoimmunity: a trigger for multiple sclerosis?
Published 2014-09-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
274
Multisequence magnetic resonance neurography of brachial and lumbosacral plexus in chronic inflammatory demyelinating polyneuropathy: correlations with electrophysiological paramet...
Published 2023-02-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
275
Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study
Published 2025-02-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
276
Endovascular treatment for anterior circulation large-vessel occlusion ischemic stroke with low ASPECTS: a systematic review and meta-analysis
Published 2022-11-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
277
Link between post-stroke psychopathology and scope-of-action awareness
Published 2024-10-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
278
Objective and self-perceived lower limb weakness in Parkinson’s disease
Published 2022-11-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
279
Clinical relevance of neutralizing antibodies in botulinum toxin long-term treated still-responding patients with cervical dystonia
Published 2019-12-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
280
Cardiac therapies for Duchenne muscular dystrophy
Published 2023-07-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article